Adia buys into Corona Remedies
Adia joined investors in buying a 7.3% stake in Corona Remedies through an INR 7.7 bn block transaction on India’s…
Available in your choice of English or Arabic
Adia joined investors in buying a 7.3% stake in Corona Remedies through an INR 7.7 bn block transaction on India’s…
Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline
Plus: India scraps duties on 40 petrochemicals to steady supplies
The government is tapping contingency funds to secure emergency LNG cargoes as prolonged supply disruptions threaten manufacturing output and fertilizer…
Topical Indian drug maker Encube Ethicals emerges as a beneficiary as US moves away from China’s pharma supply chain
Queue